Back
Arcutis Biotherapeutics Stock Price Chart
Sponsored
ARQT
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Buy
62
ARQT
Arcutis Biotherapeutics
Last Price:
$14.98
Seasonality Move:
71.61%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.
Arcutis Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.86 | Buy |
20-day SMA: | 12.92 | Buy |
50-day SMA: | 10.81 | Buy |
200-day SMA: | 9.87 | Buy |
8-day EMA: | 14.05 | Buy |
20-day EMA: | 12.97 | Buy |
50-day EMA: | 11.57 | Buy |
200-day EMA: | 9.85 | Buy |
Arcutis Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.07 | Buy |
Relative Strength Index (14 RSI): | 67.35 | Buy |
Chaikin Money Flow: | -1962353 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.81 - 13.87) | Buy |
Bollinger Bands (100): | (8.73 - 11.87) | Buy |
Arcutis Biotherapeutics Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arcutis Biotherapeutics Stock
Is Arcutis Biotherapeutics Stock a Buy?
-
Arcutis Biotherapeutics share price is 14.97 while ARQT 8-day simple moving average is 13.86, which is a Buy signal.
-
The stock price of ARQT is 14.97 while Arcutis Biotherapeutics 20-day SMA is 12.92, which makes it a Buy.
-
Arcutis Biotherapeutics 50-day simple moving average is 10.81 while ARQT share price is 14.97, making it a Buy technically.
-
ARQT stock price is 14.97 and Arcutis Biotherapeutics 200-day simple moving average is 9.87, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Buy
62
Arcutis Biotherapeutics (ARQT)
is a Buy
Is Arcutis Biotherapeutics a Buy or a Sell?
-
Arcutis Biotherapeutics stock is rated a BuyThe current Arcutis Biotherapeutics [ARQT] share price is $14.97. The Score for ARQT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Arcutis Biotherapeutics Stock Info
Market Cap:
1.8B
Price in USD:
14.97
Share Volume:
2.3M
Arcutis Biotherapeutics 52-Week Range
52-Week High:
15.79
52-Week Low:
2.60
Buy
62
Arcutis Biotherapeutics (ARQT)
is a Buy
Arcutis Biotherapeutics Share Price Forecast
-
What is the Arcutis Biotherapeutics stock price today?The Arcutis Biotherapeutics stock price is 14.97 USD today.
-
Will ARQT stock go up or go down?Arcutis Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Arcutis Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics is not overvalued.
Is Arcutis Biotherapeutics Stock a Buy?
-
Arcutis Biotherapeutics share price is 14.97 while ARQT 8-day exponential moving average is 14.05, which is a Buy signal.
-
The stock price of ARQT is 14.97 while Arcutis Biotherapeutics 20-day EMA is 12.97, which makes it a Buy.
-
Arcutis Biotherapeutics 50-day exponential moving average is 11.57 while ARQT share price is 14.97, making it a Buy technically.
-
ARQT stock price is 14.97 and Arcutis Biotherapeutics 200-day simple moving average is 9.85, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics
Is Arcutis Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.
Technical Analysis of Arcutis Biotherapeutics
Should I short Arcutis Biotherapeutics stock?
-
ARQT Moving Average Covergence Divergence (MACD) indicator is 1.07, suggesting Arcutis Biotherapeutics is a Buy
-
Arcutis Biotherapeutics Relative Strength Index (RSI) is 67.35, which suggest Arcutis Biotherapeutics is overbought
-
The Bollinger Bands (25) for Arcutis Biotherapeutics is (10.81 - 13.87), which suggest Arcutis Biotherapeutics is a Buy
-
The Bollinger Bands (100) for Arcutis Biotherapeutics is (8.73 - 11.87), which suggest Arcutis Biotherapeutics is a Buy
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.